Clinical studies of apoptosis and proliferation in breast cancer

Endocrine-Related Cancer

Volumn 6, Issue 1, 1999, Pages 25-28

  Dowsett, M ^a   Archer, C ^a   Assersohn, L ^b   Gregory, R K ^b   Ellis, P A ^a   Salter, J ^a   Chang, J ^b   Mainwaring, P ^a   Boeddinghaus, I ^a   Johnston, S R D ^a   Powles, T J ^b   Smith, I E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN; KI 67 ANTIGEN; TAMOXIFEN;

APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; HUMAN; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; REGULATORY MECHANISM; REVIEW; TISSUE GROWTH; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HUMANS; KI-67 ANTIGEN; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PREGNANCY; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0032952758     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060025     Document Type: Review

References (16)

1. Assershon L, Powles TJ, Dowsett M, Chang J, Makris A & Trott P 1998 Changes in MIB1 expression relate to response in patients receiving primary medical therapy for carcinoma of the breast. Breast Cancer Research and Treatment 50 239.
2. Bardon S, Vignon F, Montcourrier P & Rochefort H 1987 Steroid receptor-mediated cytotoxicity of an anti-oestrogen and an anti-progestin in breast cancer cells. Cancer Research 47 1441-1448.
3. Boeddinghaus IM, Johnston SR, Riddler S, Jarman M & Dowsett M 1999 Idoxifene antagonises oestradiol-dependent MCF-7 breast cancer xenograft growth by sustained apoptosis. Proceedings of the American Breast Cancer Research (In press).
4. Cameron DA, Ritchie AA, Langdon S, Anderson TJ & Miller WR 1997 Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Research and Treatment 45 99-107.
5. Detre S, Salter J, Barnes DM, Riddler S, Hills M, Johnston SRD, Gillett C, A'Hern R & Dowsett M Time-related effects of oestrogen withdrawal on proliferation-and cell death-related events in MCF7 xenografts. International Journal of Cancer (in Press)
6. Ellis PA, Saccani Jotti G, Clarke R, Johnston SRD, Anderson E, Howell A, A'Hern R, Salter JM, Detre S, Nicholson R, Robertson J, Baum M, Smith IE & Dowsett M 1997a Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. International Journal of Cancer 72 608-611.
7. Ellis PA, Smith IE, McCarthy K, Detre S, Salter J & Dowsett M 1997b Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet 349 849.
8. Ellis PA, Smith IE, Detre S, Burton SA, Salter J, A'Hern R, Walsh G, Johnston SRD & Dowsett M 1998 Reduced apoptosis and proliferation and increased bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Research and Treatment 48 107-116.
9. Kyprianou N, English HF, Davidson NE & Isaacs JT 1991 Programmed cell death during regression of the MCF human breast cancer following oestrogen ablation. Cancer Research 51 162-166.
10. Mainwaring PN, Ellis PE, Salter J, Anderson E, Howell A, Nicholson RI, Robertson JF, Smith IE, Reed J & Dowsett M 1997 Immunocytochemical expression of bcl-2 and bax is unaffected by the pure antioestrogen ICI 182780 in human breast cancer. Proceedings of the American Association of Cancer Research 38 115.
11. Mainwaring PN, Ellis PA, Detre S, Smith IE & Dowsett M 1998 Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer. Journal of Clinical Pathology 51 34-37.
12. Makris A, Allred DC, Powles TJ, Dowsett M, Fernando IN, Trott PA, Ashley S, Ormerod MG, Titley JC & Osborne CK 1997 Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Research and Treatment 44 65-74.
13. Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL & Nicholson RI 1995 Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. Journal of the National Cancer Institute 87 747-750.
14. Teixeira C, Reed JC & Pratt MAC 1995 Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Research 55 3902-3907.
15. Warri AM, Huovinen RL, Laine AM, Martikainen PM & Harkonen K 1993 Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. Journal of the National Cancer Institute 85 1412-1418.
16. Wu J, Ellis PA, Makris A, Gregory RK, Powles TJ & Dowsett M 1996 Differences in ER, Ki67 and Bcl-2 expression in primary human breast cancer before and after treatment with neoadjuvant chemoendocrine therapy. Breast Cancer Research and Treatment 41 240.